Roche Venture Fund Overview
- Investor Type
- Venture Capital
- Status
- Active
- Professionals
- 4
- Investments
- 157
- Portfolio
- 29
- Exits
- 91
Roche Venture Fund General Information
Description
Founded in 2002, Roche Venture Fund is the corporate venture capital arm of Roche Holding based in Basel, Switzerland. The firm prefers to make investments in early-stage life science companies operating in the pharmaceuticals and diagnostics sectors.
Contact Information
Year Founded
2002
Investor Status
Actively Seeking New Investments
Primary Investor Type
Corporate Venture Capital
Primary Office
- Grenzacherstrasse 124
- 4070 Basel
- Switzerland
+41 061 000 00 00
Roche Venture Fund Investments (157)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| NMD Pharma | 15-Feb-2022 | Later Stage VC | 000.00 | Drug Discovery | Generating Revenue | 0000000 0000000000 00.0 |
| 0000000 0000000000 | 19-Jan-2022 | 00000 00000 | 000.00 | Drug Discovery | Startup | |
| 0000 (0000 0000000 | 22-Dec-2021 | 00000 00000 | 00.000 | Drug Discovery | Pre-Clinical Trials | 0000000 0000000000 00.0 |
| 00000000 | 07-Dec-2021 | 00000 00000 | 00000 | Laboratory Services (Healthcare) | Clinical Trials - General | |
| 00000000 | 05-Nov-2021 | 00000 00000 | 000.00 | Other Healthcare Technology Systems | Generating Revenue | 0000000 0000000000 00.0 |
| 000000 00000000000 | 24-Sep-2021 | 0000 | 00000 | Drug Discovery | Clinical Trials - Phase 1 | |
| 0000000 0000000000 | 17-May-2021 | 00000 00000 | 0000 | Drug Discovery | Stealth | 00000 0000000 00.0 |
| 0000 00000000 | 27-Apr-2021 | 00000 00000 | 00000 | Drug Discovery | Clinical Trials - Phase 1 | 000000 000000000000 00 |
| Entrada Therapeutics | 31-Mar-2021 | Later Stage VC | 00000 | Drug Delivery | Pre-Clinical Trials | 000000 000000000000 00 |
| Centessa Pharmaceuticals | 29-Jan-2021 | Early Stage VC | 00000 | Drug Discovery | Clinical Trials - Phase 3 |
Roche Venture Fund Exits (91)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| Entrada Therapeutics | 02-Nov-2021 | IPO | 00000 |
| 000000 00000000000 | 24-Sep-2021 | 000000000000000000 | 00000 |
| 0000 00000000000 | 10-Aug-2021 | 000000000000000000 | |
| 0000000 | 10-Jun-2021 | 0000000 000000 | 00000 |
| 00000000 000000000 | 28-May-2021 | 000 | 00000 |
| 0000000 0000000000 | 01-Apr-2021 | 000000000000000000 | 00.000 |
| 000000 00000000000 | 01-Apr-2021 | 000000000000000000 | 000.00 |
| 0000000000 | 01-Feb-2021 | 000000000 00000000 | |
| Aligos Therapeutics | 16-Oct-2020 | IPO | 00000 |
| C4 Therapeutics | 02-Oct-2020 | IPO | 00000 |
Roche Venture Fund Investments by Industry, Year, and Region
Investments by Industry
Investments by Year
Investments by Region
PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.
Request a free trialRoche Venture Fund Team (13)
| Name | Title | Deals | Funds | Boards | Office |
|---|---|---|---|---|---|
| Carole Nuechterlein JD | Head of Venture Fund | 00 | 0 | 00 | Basel, Switzerland |
| David Evans | Investment Director | Basel, Switzerland | |||
| Nisha Marathe Ph.D | Investment Director | 0 | 0 | 0 | South San Francisc, CA |
| Gabriella Zöch | Project Manager | Basel, Switzerland | |||
| Monique Schiersing Ph.D | Senior Investment Director | 00 | 0 | 0 | Basel, Switzerland |
Roche Venture Fund Co-Investors (158)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| 5AM Ventures | 7 | 00 |
|
|
|
| Boxer Capital | 0 | 0 | 0 |
|
|
| Janus Henderson Investors | 0 | 0 |
|
|
|
| Logos Capital | 0 | 0 |
|
|
|
| Wellington Management | 0 | 0 |
|
|